-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ESR-114
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ESR-114 Drug Details ESR-114 is under development for the treatment of plaque psoriasis. The...
-
Product Insights
ESR Nagoya Minami Distribution Center 2
Equip yourself with the essential tools needed to make informed and profitable decisions with our ESR Nagoya Minami Distribution Center 2 report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? ·Unleash the full story: Dive deep into the...
-
Product Insights
Net Present Value Model: OP-1250
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model OP-1250 Drug Details OP-1250 is under...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – OP-1250
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry OP-1250 Drug Details OP-1250 is under development for the treatment of metastatic HR positive...
-
Product Insights
ESR Cayman – Cranbourne West Tullamore Business Park – Victoria
Equip yourself with the essential tools needed to make informed and profitable decisions with our ESR Cayman - Cranbourne West Tullamore Business Park - Victoria report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...